Company intelligence / Profile preview

Return on Focus

Wayne, Pennsylvania, United Statesreturnonfocus.com ↗

Ownership: Private
Development stage: Other

Overview

Return on Focus (ROF) does not develop therapeutics or diagnostics; it provides strategic marketing and brand consultancy services to pharmaceutical and biotechnology companies, helping them define positioning, messaging, and go-to-market strategies for their products.

Industry: Consulting

Partnerships

Works with various pharmaceutical and biotechnology companies, including Fortune 500 manufacturers and small biotechs preparing to launch new molecular entities. Over the past five years, has worked with more than 40 companies including 7 of the top 10 global pharma/biotech firms.

Beyond the preview

Go deeper on Return on Focus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Return on Focus.

Explore the full profile